|
SleepInfo.org A
Patient & Physician Education Website |
Home
Sleep Apnea Insomnia
Narcolepsy Insufficient Sleep
Sleep Studies Board Review Contact
Us |
|
|
Sleep Board Review Test 17. Which of the following is not a benzodiazepine
receptor agonist approved by the FDA for the treatment of insomnia? a. triazolam b. zolpidem c. ramelteon d. temazepam e. zaleplon Answer: c. ramelteon Ramelteon is a selective melatonin receptor agonist. It binds to the MT1 and MT2
receptors. It does not bind to
the benzodiazepine receptor (i.e. the GABA receptor). Triazolam
and temazepam are benzodiazepines. Zolpidem and
zaleplon are non-benzodiazepine benzodiazepine
receptor agonists. All of these
medications are approved by the FDA for the treatment of insomnia. Reference: Kryger et al, Principles and Practice of Sleep Medicine,
4th edition, 2005; page 445. |
|
|
The information contained in
SleepInfo.org is not a substitute for medical advice or treatment. Usage of this website constitutes
agreement to the Terms of Use. ©2007-9 SleepInfo.org |